» Articles » PMID: 33071085

Effect of Heart Failure on the Outcome of COVID-19 - A Meta Analysis and Systematic Review

Overview
Journal Am J Emerg Med
Specialty Emergency Medicine
Date 2020 Oct 19
PMID 33071085
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several comorbidities have been associated with an increased risk of severity and mortality in coronavirus disease 2019 (COVID-19), including hypertension, diabetes, cerebrovascular disease, chronic kidney disease, and chronic obstructive pulmonary disease.

Purpose: In this systematic review and meta-analysis, we attempted to investigate the association between heart failure (HF) and poor outcome in patients with COVID-19.

Methods: We performed a systematic literature search from PubMed, EuropePMC, SCOPUS, Cochrane Central Database, and medRxiv with the search terms, "Heart failure" and "COVID-19". The outcome of interest was mortality and poor prognosis (defined by incidence of severe COVID-19 infection, admission to ICU, and use of ventilator) in patients with preexisting heart failure with coronavirus disease.

Results: We identified 204 potential articles from our search, and 22 duplicates were removed. After screening of the titles and abstracts of the remaining 182 articles we identified 92 potentially relevant articles. We excluded 74 studies due to the following reasons: four studies were systematic reviews, two studies were meta-analyses, three articles were literature reviews, and 65 articles did not report on the outcome of interest. Finally, we included the remaining 18 studies in our qualitative synthesis and meta-analysis. There were 21,640 patients from 18 studies. HF was associated with hospitalization in COVID19 HR was 2.37 [1.48, 3.79; p < 0.001], high heterogeneity [I, 82%; p < 0.001]. HF was associated with a poor outcome demonstrated by an OR of 2.86 [2.07; 3.95; p < 0.001] high heterogeneity [I, 80%; p < 0.001]. Patient with preexisting HF was associated with higher mortality OR of 3.46 [2.52, 4.75; p < 0.001] moderately high heterogeneity [I, 77%; p < 0.001].

Conclusion: Patients with heart failure are at increased risk for hospitalization, poor outcome, and death from COVID-19. A significant difference in mortality between patients with and without heart failure was observed, patients with heart failure having a higher mortality.

Citing Articles

Trends and outcomes of heart failure hospitalizations during COVID-19 pandemic.

Rubens M, Ramamoorthy V, Saxena A, Khosla A, Doke M, McGranaghan P BMC Public Health. 2025; 25(1):864.

PMID: 40038630 PMC: 11881331. DOI: 10.1186/s12889-025-21995-y.


Association among diabetes, cardiovascular disease and mortality in patients hospitalised for COVID-19: an analysis of the American Heart Association COVID-19 CVD Registry.

Gujral U, Vanasse L, Goyal A, Quyyumi A, Ayers C, Das S BMJ Open. 2024; 14(12):e084087.

PMID: 39632106 PMC: 11624769. DOI: 10.1136/bmjopen-2024-084087.


Editorial comment to "Impact of COVID-19 infection on the in-hospital outcome of patients hospitalized for heart failure with comorbid atrial fibrillation: Insight from National Inpatient Sample (NIS) database 2020".

Mukai Y J Arrhythm. 2024; 40(4):903-904.

PMID: 39139907 PMC: 11317721. DOI: 10.1002/joa3.13093.


Impact of COVID-19 infection on the in-hospital outcome of patients hospitalized for heart failure with comorbid atrial fibrillation: Insight from the National Inpatient Sample (NIS) database 2020.

Wattanachayakul P, Suenghataiphorn T, Srikulmontri T, Rujirachun P, Malin J, Danpanichkul P J Arrhythm. 2024; 40(4):895-902.

PMID: 39139900 PMC: 11317655. DOI: 10.1002/joa3.13071.


Longer Hospitalizations and Higher In-Hospital Mortality for Acute Heart Failure during the COVID-19 Pandemic in Larger vs. Smaller Cardiology Departments: Subanalysis of the COV-HF-SIRIO 6 Multicenter Study.

Ostrowska M, Kasprzak M, Stolarek W, Grzelakowska K, Krys J, Kubica A Rev Cardiovasc Med. 2024; 23(9):292.

PMID: 39077718 PMC: 11262386. DOI: 10.31083/j.rcm2309292.


References
1.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

2.
Pranata R, Tondas A, Huang I, Lim M, Siswanto B, Meyer M . Potential role of telemedicine in solving ST-segment elevation dilemmas in remote areas during the COVID-19 pandemic. Am J Emerg Med. 2020; 42:242-243. PMC: 7274956. DOI: 10.1016/j.ajem.2020.06.012. View

3.
Pranata R, Permana H, Huang I, Lim M, Soetedjo N, Supriyadi R . The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Diabetes Metab Syndr. 2020; 14(5):983-990. PMC: 7319940. DOI: 10.1016/j.dsx.2020.06.047. View

4.
Ebinger J, Achamallah N, Ji H, Claggett B, Sun N, Botting P . Pre-existing traits associated with Covid-19 illness severity. PLoS One. 2020; 15(7):e0236240. PMC: 7377468. DOI: 10.1371/journal.pone.0236240. View

5.
Panhwar M, Kalra A, Gupta T, Kolte D, Khera S, Bhatt D . Effect of Influenza on Outcomes in Patients With Heart Failure. JACC Heart Fail. 2019; 7(2):112-117. DOI: 10.1016/j.jchf.2018.10.011. View